Galmed Pharmaceuticals Files 6-K Report
Ticker: GLMD · Form: 6-K · Filed: Apr 9, 2026 · CIK: 0001595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, disclosure, routine-filing
TL;DR
Galmed Pharma filed a 6-K on 4/9/26, standard foreign issuer report.
AI Summary
Galmed Pharmaceuticals Ltd. filed a Form 6-K on April 9, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and an exhibit (EX-99.1). The company's mailing and business addresses are listed as C/O MEITAR LAW OFFICES in Ramat Gan, Israel.
Why It Matters
This filing provides routine updates for Galmed Pharmaceuticals Ltd. as a foreign issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Filer
- MEITAR LAW OFFICES (company) — Mailing and Business Address
- 0001595353 (company) — Galmed Pharmaceuticals Ltd. CIK
- 2026-04-09 (date) — Filing Date and Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing made?
The filing date was April 9, 2026.
Who is the filer of this document?
The filer is Galmed Pharmaceuticals Ltd.
What are the listed addresses for Galmed Pharmaceuticals Ltd. in this filing?
The mailing and business addresses are both listed as C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN L3 5250608.
What are the document types included in this filing?
The filing includes the 6-K form itself and an exhibit labeled EX-99.1.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2026 regarding Galmed Pharmaceuticals Ltd. (GLMD).